Dr. Scott Mayer Friedman, MD

Dr. Friedman practices at Florida Retina Consultants P.A. in Lakeland, Florida.

Dr. Friedman's NPI, 1497842314, was assigned on October 10, 2006. Dr. Friedman graduated from University of Missouri School of Medicine in 1983. Dr. Friedman holds Florida license ME57010.

Dr. Friedman's primary practice is Florida Retina Consultants P.A., at 2202 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 682-7474.

Dr. Friedman's primary practice is Florida Retina Consultants P.A. in Lakeland, Florida. Dr. Friedman is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Florida Medical Clinic Orlando Health. Dmand AI also links Dr. Friedman to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Friedman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Friedman's licenses on file in 3 states: Florida, Michigan and Illinois.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, hypertensive retinopathy, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion and surgical retina and vitreous procedures among the conditions Dr. Friedman treats.

CMS data shows 228,583 Medicare services from Dr. Friedman across 15 procedure codes in 2024, for 421 Medicare patients. Medicare paid $1,414,640 for them.

CMS counts 421 Medicare patients who saw Dr. Friedman in 2024. The largest group is 75 to 84, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 73, with 54% women.

In 2024, Dr. Friedman wrote 501 Medicare Part D claims for 170 patients. 41% of them were for generic drugs. CMS names the drug for 428 of them, across 7 drugs with 11 or more claims each, at $8,826 in total drug cost. In 2023, CMS named 334 claims across 10 drugs.

Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 45 papers to Dr. Friedman, published from 2008 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Visual Acuity, Diabetic Retinopathy and Macular Edema. Dr. Friedman has published most often in JAMA Ophthalmol. Dr. Friedman's most frequent co-authors are Curtis E. Margo, MD, Adam Glassman, MD and Lee M. Jampol, MD.

Dmand AI links Dr. Friedman to 5 clinical trials. Conditions studied include Diabetic Retinopathy, Macular Degeneration and Diabetic Angiopathies. Jaeb Center for Health Research sponsors the most, 2. Open Payments lists research payments to Dr. Friedman that name 2 trials.

CMS Open Payments shows 285 general payments to Dr. Friedman from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 44% of the total. Genentech, Inc. paid the most, $7,666. It also lists 17 research payments totaling $6,751 from 2017 to 2025, naming 2 clinical trials.

Dmand AI lists 3 awards for Dr. Friedman.

Dr. Friedman graduated from University of Missouri School of Medicine in 1983. Dr. Friedman is a member of AAO and ACS.

Dr. Friedman is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.